Home

alternativ Muskulös Handful teva news reuters grammatik transient ta en bild

US judge overturns Eli Lilly's $176.5 million loss in Teva patent case |  Reuters
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case | Reuters

Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN  Business
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business

InnovationRx: Israel Makes Up 8% Of Teva's Global Production
InnovationRx: Israel Makes Up 8% Of Teva's Global Production

Biden Admin Urges Supreme Court to Hear 'Skinny Labels' Case Between Teva,  GSK
Biden Admin Urges Supreme Court to Hear 'Skinny Labels' Case Between Teva, GSK

Teva Pharmaceutical Industries – The Forward
Teva Pharmaceutical Industries – The Forward

Teva's $420mn investor settlement to be mostly covered by insurers | The  Insurer
Teva's $420mn investor settlement to be mostly covered by insurers | The Insurer

Teva says Israel-Hamas war not hurting production, eyes growth in 2024 |  Reuters
Teva says Israel-Hamas war not hurting production, eyes growth in 2024 | Reuters

Teva, AbbVie finalize $6.6 billion U.S. opioid settlements | Reuters
Teva, AbbVie finalize $6.6 billion U.S. opioid settlements | Reuters

Israel's Teva agrees to pay $126 mln to US hospitals over opioids
Israel's Teva agrees to pay $126 mln to US hospitals over opioids

Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters

Why Europe's Drug Shortages May Get Worse
Why Europe's Drug Shortages May Get Worse

Teva Pharm to lay off a quarter of workforce, suspends dividend By Reuters
Teva Pharm to lay off a quarter of workforce, suspends dividend By Reuters

Teva in Talks to Buy Allergan's Generic-Drug Unit - WSJ
Teva in Talks to Buy Allergan's Generic-Drug Unit - WSJ

Drugmaker Teva does not see big impact on business from Israel-Hamas war |  Reuters
Drugmaker Teva does not see big impact on business from Israel-Hamas war | Reuters

Teva Pharm Expects About 25 Percent of EpiPen Market by Year End
Teva Pharm Expects About 25 Percent of EpiPen Market by Year End

Fears of Israeli job cuts at Teva sparks call for general strike | Reuters
Fears of Israeli job cuts at Teva sparks call for general strike | Reuters

Teva delays 33% of Jerusalem layoffs until 2019 - Israel News - The  Jerusalem Post
Teva delays 33% of Jerusalem layoffs until 2019 - Israel News - The Jerusalem Post

Price-fixing lawsuit deals another blow to already fragile Teva, experts  say | The Times of Israel
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel

Mylan's Chairman was Right | Ctech
Mylan's Chairman was Right | Ctech

Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business -  Haaretz.com
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com

What's 'down' with Teva? - Israel News - The Jerusalem Post
What's 'down' with Teva? - Israel News - The Jerusalem Post

Teva Pharmaceutical Set for Major Layoffs in Israel, U.S.: Report
Teva Pharmaceutical Set for Major Layoffs in Israel, U.S.: Report

Jury finds Teva fueled opioid addiction in New York - YouTube
Jury finds Teva fueled opioid addiction in New York - YouTube

Teva drops migraine-drug patent case against Eli Lilly | Nasdaq
Teva drops migraine-drug patent case against Eli Lilly | Nasdaq

Teva enters billion-dollar settlement in US opioid case — MedWatch
Teva enters billion-dollar settlement in US opioid case — MedWatch